Skip to main content
Home

oAv Menu

  • Home
  • Patient Care Center
  • Clinical Trials
  • Providers
    • Therapeutics
    • People
    • Places
  • Community Center
    • Community Stories
    • Social Media
    • Community Content
    • Financial Assistance
  • News
    • Community Events
    • Clinical Trials and Research
    • Business
    • News People
    • Happenings
    • Spotlight
    • Fundraising Events
  • Trusted Resources
    • Education
    • Videos & Visuals
  • Event Calendar
  • Login
  • Search

Education

  • Patient Education
  • Scientific Articles
  • Guides & Guidelines
  • Abstract & Posters
  • Reference Materials
  1. Home
  2. Trusted Resources
  3. Education
 Emerging Therapies and Treatment Considerations for ATTR Amyloidosis
Feb 28, 2026
Emerging Therapies and Treatment Considerations for ATTR Amyloidosis
Read more
Persicaria hydropiper attenuates oxidative stress and reactive oxygen species, and inhibits amyloid-β/tau in SH-SY5Y cell lines via multiple pathways of Alzheimer's disease
Feb 13, 2026
Persicaria hydropiper attenuates oxidative stress and reactive oxygen species, and inhibits amyloid-β/tau in SH-SY5Y cell lines via multiple pathways of Alzheimer's disease
Read more
The Beat Episode 20: ATTR Cardiac Amyloidosis: Bridging Heart Failure and Rhythm Management (On-Demand)
Feb 13, 2026
The Beat Episode 20: ATTR Cardiac Amyloidosis: Bridging Heart Failure and Rhythm Management (On-Demand)
Read more
3D Visualization and Proteomic Analysis of Human Cardiac Transthyretin Amyloidosis Tissue Reveals Microangiopathy and Capillary Occlusion
Feb 11, 2026
3D Visualization and Proteomic Analysis of Human Cardiac Transthyretin Amyloidosis Tissue Reveals Microangiopathy and Capillary Occlusion
Read more
New Cardiac Amyloidosis Treatments Improve Quality and Length of Life.
Feb 11, 2026
New Cardiac Amyloidosis Treatments Improve Quality and Length of Life.
Read more
Postdoctoral Researcher - Structural Spectroscopy of Amyloid Aggregates
Feb 09, 2026
Postdoctoral Researcher - Structural Spectroscopy of Amyloid Aggregates
Read more
Advocating for Yourself With Your Doctor
Feb 04, 2026
Advocating for Yourself With Your Doctor
Read more
Rare Disease Day® and ATTR Amyloidosis
Feb 04, 2026
Rare Disease Day® and ATTR Amyloidosis
Read more
ashpublications
Jan 27, 2026
Clinical Features of Systemic Amyloidosis: A Scoping Review
Read more
CRISPR-Cas3
Jan 21, 2026
https://www.oreateai.com/blog/understanding-hattr-a-deep-dive-into-hereditary-transthyretin-amyloidosis/23903414f6a0a602d9aca557d23f138c
Read more

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • ›› Next page
  • Last » Last page
Subscribe to

Newsletter

Stay informed - subscribe to our newsletter.
The subscriber's email address.

RNAi Explained

Dr. Bersell explores RNA interference (RNAi) technology and its applications in treating ATTR-CM and ATTR-PN. Learn about mechanism of action, clinical evidence, and patient outcomes.

Learn More

Expert Perspectives on Attruby®

Dr. Barry Trachtenberg and ATTR community members discuss Attruby™ (acoramidis), covering clinical data, patient perspectives, and treatment considerations.

Watch Discussion

Featured Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis

Footer menu

  • Home
  • About us
  • Video
  • Galleries
  • Contact
  • Login
  • Privacy Policy
  • Privacy Reminder
  • Terms of use
  • FAQ
  • Code of Conduct

© 2025 Somebody To Talk To, Inc.

Join us on